(Q46249026)

20 December 2017

title

Low-dose theophylline reduces symptoms of acute mountain sickness (English)

1 reference

20 December 2017

2

Kingman P Strohl

1 reference

20 December 2017

author name string

Thomas E A H Küpper

1

1 reference

20 December 2017

Markus Hoefer

3

1 reference

20 December 2017

Ulf Gieseler

4

1 reference

20 December 2017

Cordula M Netzer

5

1 reference

20 December 2017

Nikolaus C Netzer

6

1 reference

20 December 2017

publication date

1 September 2008

1 reference

20 December 2017

Journal of Travel Medicine

published in

1 reference

20 December 2017

volume

15

1 reference

20 December 2017

issue

5

1 reference

20 December 2017

page(s)

307-314

1 reference

20 December 2017

Prevalence of acute mountain sickness in the Swiss Alps

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Incidence of acute mountain sickness at intermediate altitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

The incidence, importance, and prophylaxis of acute mountain sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

21 January 2018

High-altitude illness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

21 January 2018

High-Altitude Illness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Update: High altitude pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Endothelial barrier dysfunction and oxidative stress: roles for nitric oxide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Increased oxidative stress following acute and chronic high altitude exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Acute mountain sickness is associated with sleep desaturation at high altitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Acute mountain sickness is related to nocturnal hypoxemia but not to hypoventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Nocturnal oxygen enrichment of room air at 3800 meter altitude improves sleep architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Renal carbonic anhydrase inhibition reduces high altitude sleep periodic breathing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Effects of dexamethasone on the incidence of acute mountain sickness at two intermediate altitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Dexamethasone in the treatment of acute mountain sickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Pharmacologic treatment of sleep-disordered breathing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Sleep and Breathing at High Altitude.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Chemosensitivity and regulation of ventilation during sleep at high altitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Operation Everest II: arterial oxygen saturation and sleep at extreme simulated altitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Anti-oxidative effects of theophylline on human neutrophils involve cyclic nucleotides and protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00228.X

10.1111/J.1708-8305.2008.00228.X

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017